A detailed history of Spire Wealth Management transactions in Baxter International Inc stock. As of the latest transaction made, Spire Wealth Management holds 4,271 shares of BAX stock, worth $140,302. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,271
Previous 4,169 2.45%
Holding current value
$140,302
Previous $161,000 13.04%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$37.88 - $43.77 $3,863 - $4,464
102 Added 2.45%
4,271 $182,000
Q4 2023

Feb 06, 2024

SELL
$31.71 - $38.95 $2,949 - $3,622
-93 Reduced 2.18%
4,169 $161,000
Q3 2023

Nov 08, 2023

BUY
$37.32 - $49.29 $37,431 - $49,437
1,003 Added 30.78%
4,262 $160,000
Q2 2023

Aug 09, 2023

BUY
$39.98 - $47.68 $3,997 - $4,768
100 Added 3.17%
3,259 $148,000
Q1 2023

May 09, 2023

BUY
$37.58 - $52.57 $50,469 - $70,601
1,343 Added 73.95%
3,159 $128,000
Q4 2022

Feb 03, 2023

SELL
$49.7 - $57.71 $12,723 - $14,773
-256 Reduced 12.36%
1,816 $93,000
Q3 2022

Nov 07, 2022

SELL
$53.86 - $66.8 $130,610 - $161,990
-2,425 Reduced 53.92%
2,072 $112,000
Q2 2022

Jul 22, 2022

SELL
$63.83 - $80.0 $7,595 - $9,520
-119 Reduced 2.58%
4,497 $289,000
Q1 2022

Apr 18, 2022

SELL
$76.85 - $89.45 $69,472 - $80,862
-904 Reduced 16.38%
4,616 $358,000
Q4 2021

Jan 14, 2022

SELL
$74.57 - $87.19 $108,126 - $126,425
-1,450 Reduced 20.8%
5,520 $474,000
Q3 2021

Oct 22, 2021

SELL
$73.77 - $83.61 $59,089 - $66,971
-801 Reduced 10.31%
6,970 $561,000
Q2 2021

Jul 26, 2021

SELL
$80.5 - $88.01 $56,672 - $61,959
-704 Reduced 8.31%
7,771 $626,000
Q1 2021

May 21, 2021

BUY
$76.38 - $86.03 $647,320 - $729,104
8,475 New
8,475 $716,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.